162 related articles for article (PubMed ID: 37368028)
1. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.
Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028
[TBL] [Abstract][Full Text] [Related]
2. Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells.
Pashizeh F; Mansouri A; Bazzazan S; Abdihaji M; Khaleghian M; Bazzazan S; Rezei N; Eskandari A; Mashayekhi F; Heydari M; Tavakkoli Yaraki M
Int J Biol Macromol; 2024 Feb; 258(Pt 2):128957. PubMed ID: 38154726
[TBL] [Abstract][Full Text] [Related]
3. The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Akbarzadeh I; Farid M; Javidfar M; Zabet N; Shokoohian B; Arki MK; Shpichka A; Noorbazargan H; Aghdaei HA; Hossein-Khannazer N; Timashev P; Makvandi P; Vosough M
AAPS PharmSciTech; 2022 Jan; 23(1):57. PubMed ID: 35048234
[TBL] [Abstract][Full Text] [Related]
4. Folate-Targeted Curcumin-Loaded Niosomes for Site-Specific Delivery in Breast Cancer Treatment: In Silico and In Vitro Study.
Honarvari B; Karimifard S; Akhtari N; Mehrarya M; Moghaddam ZS; Ansari MJ; Jalil AT; Matencio A; Trotta F; Yeganeh FE; Farasati Far B; Arki MK; Naimi-Jamal MR; Noorbazargan H; Lalami ZA; Chiani M
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889513
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Gingerol-loaded Uio-66 nanoparticles and its anti-cancer effect against gastric cancer cell line (AGS).
Kazazi I; Ashrafi F; Malekloo M
Mol Biol Rep; 2023 Apr; 50(4):3503-3513. PubMed ID: 36787050
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
[TBL] [Abstract][Full Text] [Related]
7. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
[TBL] [Abstract][Full Text] [Related]
8. Folic Acid-Decorated pH-Responsive Nanoniosomes With Enhanced Endocytosis for Breast Cancer Therapy:
Rezaei T; Rezaei M; Karimifard S; Mahmoudi Beram F; Dakkali MS; Heydari M; Afshari-Behbahanizadeh S; Mostafavi E; Bokov DO; Ansari MJ; Farasati Far B; Akbarzadeh I; Chaiyasut C
Front Pharmacol; 2022; 13():851242. PubMed ID: 35517801
[TBL] [Abstract][Full Text] [Related]
9. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation.
Hosseini F; Mirzaei Chegeni M; Bidaki A; Zaer M; Abolhassani H; Seyedi SA; Nabipoorashrafi SA; Ashrafnia Menarbazari A; Moeinzadeh A; Farmani AR; Tavakkoli Yaraki M
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124697. PubMed ID: 37156313
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M
Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-gingerol encapsulated niosomal formulation against carbapenem-resistant
Karbalaeiheidar H; Ashrafi F
Biomed Mater; 2023 May; 18(4):. PubMed ID: 37187182
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy.
Khodabakhsh F; Bourbour M; Yaraki MT; Bazzazan S; Bakhshandeh H; Ahangari Cohan R; Tan YN
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080186
[TBL] [Abstract][Full Text] [Related]
13. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
[TBL] [Abstract][Full Text] [Related]
14. pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer.
Moammeri A; Abbaspour K; Zafarian A; Jamshidifar E; Motasadizadeh H; Dabbagh Moghaddam F; Salehi Z; Makvandi P; Dinarvand R
ACS Appl Bio Mater; 2022 Feb; 5(2):675-690. PubMed ID: 35129960
[TBL] [Abstract][Full Text] [Related]
15. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
[TBL] [Abstract][Full Text] [Related]
16. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
17. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU.
He RX; Ye X; Li R; Chen W; Ge T; Huang TQ; Nie XJ; Chen HJ; Peng DY; Chen WD
J Liposome Res; 2017 Jun; 27(2):161-170. PubMed ID: 27184460
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
[TBL] [Abstract][Full Text] [Related]
19. Preparation, Optimization and In vitro Evaluation of Doxorubicin-loaded into Hyaluronic Acid Coated Niosomes Against Breast Cancer.
Faddah H; Nsairat H; Shalan NM; El-Tanani M; Alqudah DA; Alshaer W
Chem Biodivers; 2024 Feb; 21(2):e202301470. PubMed ID: 38161147
[TBL] [Abstract][Full Text] [Related]
20. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy.
Safari Sharafshadeh M; Tafvizi F; Khodarahmi P; Ehtesham S
Int J Biol Macromol; 2023 Apr; 235():123686. PubMed ID: 36801304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
